Suppr超能文献

组蛋白去乙酰化酶抑制剂 - 新一代靶向特异性治疗药物。

HDAC inhibitors - new generation of target specific treatment.

机构信息

Department of Medicinal Chemistry, Bharati Vidyapeeth's College of Pharmacy, CBD-Belapur, Navi Mumbai-400614, Maharashtra, India.

出版信息

Mini Rev Med Chem. 2010 Nov;10(13):1263-76. doi: 10.2174/13895575110091263.

Abstract

Histone Deacetylases (HDACs) enzymes are critical in regulating gene expression and transcription. They also play a fundamental role in regulating cellular activities such as cell proliferation, survival and differentiation. Inhibition of HDACs has generated many fascinating results including a new strategy in human cancer therapy. HDAC Inhibitors (HDACIs) like SAHA, TSA are emerging as new promising drugs for various anti-inflammatory and CNS-disorders. This review, along with chemical classification, emphasizes on the therapeutic potential of various HDACIs against different diseases.

摘要

组蛋白去乙酰化酶(HDACs)酶在调节基因表达和转录中起着关键作用。它们在调节细胞活动方面也起着至关重要的作用,如细胞增殖、存活和分化。HDAC 的抑制产生了许多引人注目的结果,包括人类癌症治疗的新策略。SAHA、TSA 等 HDAC 抑制剂(HDACIs)作为各种抗炎和中枢神经系统疾病的新的有前途的药物正在出现。本综述结合化学分类,强调了各种 HDACIs 对不同疾病的治疗潜力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验